Last $59.20 USD
Change Today +0.125 / 0.21%
Volume 153.2K
ICUI On Other Exchanges
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

icu medical inc (ICUI) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/1/13 - $85.00
52 Week Low
05/5/14 - $54.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ICU MEDICAL INC (ICUI)

icu medical inc (ICUI) Related Businessweek News

No Related Businessweek News Found

icu medical inc (ICUI) Details

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, oncology, and critical care applications. It operates in three segments: Infusion Therapy, Critical Care, and Oncology. The company’s product line includes needlefree infusion connectors, custom infusion systems, catheters and hemodynamic monitoring systems, closed system transfer devices, and automated compounders for handling hazardous drugs. Its products enhance patient outcomes by preventing bloodstream infections, and protecting healthcare workers and patients from exposure to infectious diseases or hazardous drugs. The company offers I.V. therapy lines consisting of a tube running from a bottle or plastic bag containing an I.V. solution to a catheter inserted in a patient’s vein for use in hospitals and ambulatory clinics; and Clave product, a needlefree infusion connection device, which is used with conventional peripheral or central vascular access systems for venous and arterial applications. It also provides critical care products that monitor vital signs and specific physiological functions of key organ systems, including disposable pressure-sensing devices, blood sampling systems, minimally invasive monitoring sensors, catheters, and angiography kits for various purposes. In addition, the company provides a line of oncology products, including ChemoLock and ChemoClave closed system transfer device and components, including Genie closed vial access device and Spiros closed male luer; custom preparation and administration sets and accessories; and Diana hazardous drug compounding system. Further, it offers Tego needlefree hemodialysis connectors and Lopez enteral valves. ICU Medical, Inc. sells its products to medical product manufacturers, independent distributors, and directly to end users. The company was founded in 1984 and is headquartered in San Clemente, California.

2,269 Employees
Last Reported Date: 02/21/14
Founded in 1984

icu medical inc (ICUI) Top Compensated Officers

Chief Financial Officer, Treasurer and Secret...
Total Annual Compensation: $406.6K
Vice President of Operations
Total Annual Compensation: $399.4K
Vice President of Product Development
Total Annual Compensation: $315.0K
Compensation as of Fiscal Year 2013.

icu medical inc (ICUI) Key Developments

ICU Medical, Inc. Approves Amendments to its Certificate of Incorporation

ICU Medical, Inc. at its Annual Meeting of Stockholders held on June 9, 2014, approved an amendment to and restatement of the company's Certificate of Incorporation.

ICU Medical, Inc. Presents at Goldman Sachs 35th Annual Global Healthcare Conference, Jun-11-2014 09:20 AM

ICU Medical, Inc. Presents at Goldman Sachs 35th Annual Global Healthcare Conference, Jun-11-2014 09:20 AM. Venue: Terranea Resort in Rancho Palos Verdes, 100 Terranea Way, Los Angeles, California, United States. Speakers: Scott E. Lamb, Chief Financial Officer, Treasurer and Secretary, Vivek Jain, Chairman and Chief Executive Officer.

ICU Medical, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014; Reaffirms Earnings Guidance for the Year 2014; Provides Capex Guidance for the Year 2015

ICU Medical, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported total revenue of $73,230,000 against $74,299,000 a year ago. Income from operations was $9,877,000 against $12,025,000 a year ago. Income before income taxes was $10,087,000 against $12,193,000 a year ago. Net income was $6,657,000 or $0.43 per diluted share against $8,685,000 or $0.58 per diluted share a year ago. Net cash provided by operating activities was $12,714,000 against $10,764,000 a year ago. Purchases of property and equipment were $5,908,000 against $5,831,000 a year ago. Intangible asset additions were $120,000 against $355,000 a year ago. Adjusted EBITDA was $16,825,000 against $18,617,000 a year ago. Adjusted diluted earnings per share were $0.72 against $0.81 a year ago. Net income was also impacted by a higher tax rate of 34% compared to the same period last year rate of 28.8%, which included discrete items. For the full fiscal year of 2014, management reaffirms its previously announced guidance and expects to generate revenue in the range of $285 million to $300 million, GAAP fully diluted earnings per share in the range of $1.15 to $1.45 adjusted fully diluted earnings per share in the range of $2.45 to $2.75, and adjusted EBITDA in the range of $58 million to $65 million. GAAP net income to be $17,922,000 to $22,637,000. The company expects gross margin to be approximately 50%. The company expects capex to start declining in 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICUI:US $59.20 USD +0.125

ICUI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cyberonics Inc $58.51 USD -0.41
Exactech Inc $22.25 USD -1.03
Merit Medical Systems Inc $14.82 USD -0.22
Tornier NV $21.26 USD -0.32
Wright Medical Group Inc $31.30 USD -0.42
View Industry Companies

Industry Analysis


Industry Average

Valuation ICUI Industry Range
Price/Earnings 23.6x
Price/Sales 2.9x
Price/Book 1.9x
Price/Cash Flow 23.4x
TEV/Sales 1.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ICU MEDICAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at